Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

New NEA Fund Could Bring $1 Billion To Health Care

May 22 2015

• By Tom Salemi

Related Content

Timing, Returns Record Right For Vivo Capital Fundraising

Apr 20 2015

Newly Public Medtechs Gain In Share Price, Market Cap

May 12 2015

Going More Than Skin Deep Into Merz’s Ulthera Acquisition

Nov 10 2014

Abbott, NEA Show Medtech Deals Still Have Some Pop

Dec 11 2014

Related Companies

Nevro Corp.

TriVascular Technologies, Inc.

Merz Pharmaceuticals GmbH

Abbott

Abbott

VytronUS, Inc

Loxo Oncology at Lilly

Ardelyx Inc.

Trevena Inc.

Adaptimmune Therapeutics plc

Foundry Innovation and Research 1 Ltd.

Covidien plc

CRISPR Therapeutics AG

Intact Vascular Inc.

Additional Topics

BioPharmaceutical Medical Device

More from Archive

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window